Sangamo Therapeutics (SGMOQ) Other Non Operating Income (2024 - 2025)

Sangamo Therapeutics' Other Non Operating Income history runs 2 years deep, the most recent figure standing at -$21000.0 for Q4 2025.

• On a quarterly basis, Other Non Operating Income fell 101.12% year-over-year to -$21000.0 in Q4 2025; TTM through Dec 2025 was -$3.6 million, a 181.95% decrease from a year earlier, with the FY2025 full-year figure at -$3.6 million, down 181.95% from the prior year.
• Other Non Operating Income eased to -$21000.0 in Q4 2025 per SGMOQ's latest filing, from $107000.0 in the prior quarter.
• Across five years, Other Non Operating Income topped out at $2.1 million in Q1 2024 and bottomed at -$2.5 million in Q2 2025.